In summary, our findings in the newly generated mouse model for Myt1l haploinsufficiency are consistent with key elements of the clinical phenotype reported in humans, most notably obesity, hyperactivity, and reduced motor performance. This evidence concerns the gene MYT1L and obesity due to melanocortin 4 receptor deficiency.